Trademark Overview
On Wednesday, September 10, 2025, a trademark application was filed for AMDURIQ with the United States Patent and Trademark Office. The USPTO has given the AMDURIQ trademark a serial number of 99385069. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, September 10, 2025. This trademark is owned by Kymab Limited. The AMDURIQ trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of respiratory, inflammatory, and immunological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of chronic obstructive pulmonary disease (COPD); Pharmaceutical preparations for the treatment and prevention of atopic dermatitis